Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors

Journal of the American College of Cardiology

Volumn 66, Issue 21, 2015, Pages 2282-2284

  Lip, Gregory Y H ^a,b   Lane, Deirdre A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

atrial fibrillation; gastrointestinal bleeding; NOACs; oral anticoagulation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; EDOXABAN; NONSTEROID ANTIINFLAMMATORY AGENT; RIVAROXABAN; WARFARIN;

ATRIAL FIBRILLATION; BLEEDING; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHADS2 SCORE; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HAS BLED SCORE; HAZARD RATIO; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; CHEMICALLY INDUCED; FEMALE; MALE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; RIVAROXABAN; WARFARIN;

EID: 84962260217     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.07.086     Document Type: Editorial

References (16)

1. C.T. Ruff, R.P. Giugliano, E. Braunwald, and et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 2014 955 962
2. F. Skjoth, T.B. Larsen, L.H. Rasmussen, and G.Y. Lip Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis Thromb Haemost 111 2014 981 988
3. M.W. Sherwood, C.C. Nessel, A.S. Hellkamp, and et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial J Am Coll Cardiol 66 2015 2271 2281
4. V. Roldan, F. Marin, S. Manzano-Fernandez, and et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation J Am Coll Cardiol 62 2013 2199 2204
5. S. Apostolakis, D.A. Lane, H. Buller, and G.Y. Lip Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial Thromb Haemost 110 2013 1074 1079
6. G.Y. Lip, D.A. Lane, H. Buller, and S. Apostolakis Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study Chest 144 2013 1839 1847
7. A. Banerjee, L. Fauchier, A. Bernard-Brunet, N. Clementy, and G.Y. Lip Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation. The Loire Valley Atrial Fibrillation Project Thromb Haemost 111 2014 549 556
8. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
9. G.Y. Lip, and D.A. Lane Stroke prevention in atrial fibrillation: a systematic review JAMA 313 2015 1950 1962
10. National Institute for Health and Care Excellence (NICE). Atrial fibrillation: the management of atrial fibrillation [Clinical guideline 180]. 2014. Available at: https://www.nice.org.uk/guidance/cg180/resources/guidance-atrial-fibrillation-the-management-of-atrial-fibrillation-pdf. Accessed September 23, 2015.
11. P. Gallego, V. Roldan, F. Marin, and et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation Thromb Haemost 110 2013 1189 1198
12. R. De Caterina, S. Husted, L. Wallentin, and et al. Vitamin K antagonists in heart disease: current status and perspectives (section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Thromb Haemost 110 2013 1087 1107
13. C.E. Chiang, K.L. Wang, and G.Y. Lip Stroke prevention in atrial fibrillation: an Asian perspective Thromb Haemost 111 2014 789 797
14. 2 score to poor quality anticoagulation, stroke, clinically relevant bleeding and mortality in patients with atrial fibrillation Chest 146 2014 719 726
15. 2 -VASc score J Am Coll Cardiol 65 2015 1385 1394
16. 2 -VASc score (beyond sex) J Am Coll Cardiol 66 2015 488 490